FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical...
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat
STOCKHOLM, June 17, 2026 /PRNewswire/ -- Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic inflammatory diseases, today announced that 50% of the target of 190 patients have been randomized in its Phase 2 clinical proof-of-concept trial (NOVA). The study is evaluating vipoglanstat, a novel, non-hormonal, non-opioid drug candidate for the treatment of endometriosis. This...
Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026
HONG KONG, June 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) were presented as an oral presentation at the 2026 European Hematology Association (EHA) Congress. Ligufalimab is Akeso's proprietary next-generation humanized IgG4 anti-CD47 monoclonal antibody. The study evaluated...
APAC healthcare systems face growing strain as rising patient expectations collide with stretched clinical workforce – Bain & Company survey
95% of consumers want a single touchpoint to manage their healthcare 84% of consumers expect greater convenience from healthcare system Three in four consumers comfortable with AI-enabled healthcare apps One in five doctors actively considering leaving their current employer due to burnout SINGAPORE, June 17, 2026 /PRNewswire/ -- Asia-Pacific...
RRS® HA Long Lasting awarded Best Injectable in Skin Revitalization at AMWC 2026, reinforcing Skin Tech Pharma Group’s leadership in the Skin Builder category
BARCELONA, Spain, June 17, 2026 /PRNewswire/ -- Skin Tech Pharma Group proudly announces that its flagship injectable, RRS® HA LONG LASTING, has been recognized as Best Injectable in the Skin Revitalization category at the AMWC Aesthetic Medicine Awards 2026, one of the most prestigious recognitions in aesthetic medicine. RRS® HA...
Ping An Good Doctor Upgrades AI Doctor Service “Ping An AI Doctor”, Expanding Access to Ping An Ecosystem’s 90 Million MAUs
HONG KONG, June 17, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company", Stock Code: 1833.HK) has recently upgraded its AI doctor service — Ping An AI Doctor. The service has been fully integrated into a number of core applications under Ping An Group, including Ping An Jin Guan Jia, Ping...
Dioseve Secures JPY 1.45 Billion to Advance iPS Cell‑Based IVF Support, Adds TIME100 Scientist as Advisor
Funding round and NEDO Deep Tech Startup Support Program selection will support development and clinical adoption of DIOS‑101, an iPS cell‑derived co‑culture designed to reduce the burden of IVF treatment. TOKYO, June 17, 2026 /PRNewswire/ -- Dioseve Inc. ("Dioseve"), a Tokyo-based fertility biotech company developing iPS cell-derived ovarian support technologies for in vitro oocyte maturation to reduce the...
Ruixiang Silicone Releases Platinum-Cured Medical Silicone Tubing for Cardiac, Infusion, and Hemodialysis Device Manufacturers
USP Class VI, ISO 10993 biocompatibility evaluation, and ISO 13485:2016 quality system certification, manufactured at an FDA-registered facility DONGGUAN, China, June 16, 2026 /PRNewswire/ -- Dongguan Ruixiang Precision Silicone Products Co., Ltd. (Ruixiang Silicone) has released a platinum-cured medical-grade silicone tubing series manufactured at an FDA-registered facility and carrying USP Class VI certification, ISO 10993 biocompatibility evaluation, and...
Angel Yeast Chairman Reflects on 40 Years of Bringing Yeast to Millions of Households Worldwide
Exclusive interview highlights advances in yeast protein and yeast extracts, global expansion, sustainability, and future growth drivers SHANGHAI, June 16, 2026 /PRNewswire/ -- Angel Yeast (SSE: 600298), a global yeast and biotech company, was interviewed by Food Ingredients, a leading international trade publication, in celebration of its 40th anniversary. Chairman Xiong Tao...
NYSE Content Update: NYSE Partner Reindustrialize Kicks Off Summit from Detroit
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 16, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. OpenLoop rolls out Launchpad...
